Beyond efficacy: the STAR*D trial
- PMID: 16390879
- PMCID: PMC1586101
- DOI: 10.1176/appi.ajp.163.1.5
Beyond efficacy: the STAR*D trial
Comment on
-
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.Am J Psychiatry. 2006 Jan;163(1):28-40. doi: 10.1176/appi.ajp.163.1.28. Am J Psychiatry. 2006. PMID: 16390886 Clinical Trial.
References
-
- Tunis SR, Stryer DB, Clancy CM. Practical clinical trials: increasing the value of clinical research for decision making in clinical and health policy. JAMA. 2003;290:1624–1632. - PubMed
-
- March JS, Silva SG, Compton S, Shapiro M, Califf R, Krishnan R. The case for practical clinical trials in psychiatry. Am J Psychiatry. 2005;162:836–846. - PubMed
-
- Casalino LP. Disease management and the organization of physician practice. JAMA. 2005;293:485–488. - PubMed
-
- Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RS, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. Effectiveness of antipsychotic drugs in patients with chronic Schizophrenia. N Engl J Med. 2005;353:1286–1288. - PubMed
-
- Schneider LS, Tariot PN, Lyketsos CG, Dagerman KS, Davis KL, Davis S, Hsiao JK, Jeste DV, Katz IR, Olin JT, Pollock BG, Rabins PV, Rosenheck RA, Small GW, Lebowitz B, Lieberman JA. National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE): Alzheimer disease trial methodology. Am J Geriatr Psychiatry. 2001;9:346–360. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources